Insights from analysts' 12-month price targets are revealed, presenting an average target of $300.9, a high estimate of ...

As demand continued to recover, Accor's debt/adjusted EBITDA reached 3.9 times in 2022, 2.5 times in 2023, and 2.8 times in 2024. In 2023, Fitch Ratings upgraded Accor's debt to investment-grade.

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

The global asset management industry reached a record $128 trillion in assets under management in 2024, a 12% increase over ...

Using recent performance of fixed income and equity markets as an example, PORT modelling can provide useful insight to ...

Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

Price analysis is the ongoing process of cryptocurrency traders and analysts finding patterns in the market to determine optimal trading strategies and gauge market sentiment for the ...

Emami emerges stronger post-pandemic with rural-led revenue, ayurvedic healthcare focus, and growth potential, making it a ...

Stock Rover is a reasonably priced stock screener and research tool for advanced portfolio analysis. The platform's extensive market research on various investible securities, analysis ratings ...

A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Goldman Sachs India Equity Portfolio I Acc Usd fund. Access detailed technical analysis through moving averages buy ...

Nearly 97% of equity mutual funds delivered negative returns in 2025 so far, with only 18 out of 541 schemes posting gains. The worst performers include funds from Nippon India, Samco, and Shriram.